Tissue Microarray Market is projected to Grow at a Substantial Rate of 13.7% by 2023

Tissue microarray (TMA) is a recipient paraffin block that comprises thousands of separate tissue centers assembled in array fashion to allow multiplex histological analysis. These TMAs allow a quick, cost-effective, high through-put examination of thousands of molecular markers at nucleic acids or protein level. The Tissue Microarray Market is growing extensively. TMA is the latest advancement in the field of pathology. Different sorts of tumors at different phases of disease progression can also be studied at a single stage, in identical conditions in less labor-intensive and cost-effective ways. The global tissue microarray market is expected to grow at a CAGR of 10.88% during the forecast period 2017-2023.

Get a Sample Report @ https://www.marketresearchfuture.com/sample_request/1213 .

It is a practical and efficient tool for high-throughput molecular analysis of tissues that help to identify new diagnostic and prognostic markers. It also targets human cancers and has a range of potential applications in basic research, prognostic oncology, and drug discovery. The growing need for targeted treatments for various chronic diseases such as cancer, genetic diseases, and others has boosted the growth of the market

Increasing application in drug discovery is one of the major factors driving the market growth. During drug research and development, the risk of product failure is high. Moreover, advancement in molecular methods have massively simplified the discovery of potential molecular targets for gene-specific therapy. Application in drug discovery has generated a massive demand for such supposed targets and to meet such demand human tissue analysis is needed. Nevertheless, the need for analysis of large numbers of well-characterized human tissues constitutes a major role in the drug discovery and development. Earlier, tissue analysis used to be done in slide-by-slide manner, which was time consuming, expensive, and difficult to operate.

Increasing prevalence of cancer is one of the important factors that drives the growth of the tissue microarray market. According to the American Cancer Society, in 2017, about 1 in 8 the U.S. women (about 12%) predicted to develop invasive breast cancer over the course of her lifetime. In 2017, an estimated 252,710 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,410 new cases of non-invasive (in situ) breast cancer.

However, tissue microarray may not be fruitful for heterogeneous cancers, which may hamper the market growth over the review period.

Tissue Microarray Global Market - Key Players

The global TMA market is adorned as competitive with the presence of many well established players having presence regional and global market. Large investments are taking place in Tissue microarray market. Innovation, mergers & acquisitions, brand reinforcement and collaboration remain the key trends for leading players.

Order Single User License Copy of 182 Premium Pages is Available @ https://www.marketresearchfuture.com/reports/tissue-microarray-market-1213 .

Some of the key players in this market are: Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, Qiagen, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp, and general electric.

Brief TOC

1 Introduction

1.1 Definition
1.2 Scope Of Study

1.2.1 Research Objective
1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions
1.2.2.2 Limitations

1.3 Market Structure

2 Research Methodology

2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research

3 Market Dynamics

3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Macroeconomic Indicators

4 Market Factor Analysis

….Continued

Ask to Expert @ https://www.marketresearchfuture.com/enquiry/1213 .

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.